andy cohen glp 1 admits to 'micro-dosing' on weight-loss medication Andy Cohen saw video of

Learn about clinical benefits, dosing strategies, safety considerations, and who should consider this evidence-based combination therapy for superior glycemic management and weight loss.

Eli Lilly strikes Zepbound deal with the telehealth platform Ro, amid questions about future of compounded GLP-1s.

PlexusDx explains the science behind GLP-1 fatigue and practical management tips

Explore top LinkedIn corporate social responsibility content from experienced professionals.

GLP1 medications do more than support weight lossthey can play a meaningful role in heart health, blood sugar control and even sleep quality

and Indianapolis-based Eli Lilly, which makes Zepbound, will agree to sell their drugs to Medicare at a lower most favor